AI hype and index moves shake up valuations: RealReal, workiva, viavi, and verisk in the spotlight
The gist
AI buzz and index shake-ups are jolting valuations for RealReal, Workiva, Viavi, and Verisk—with wild swings, bold upgrades, and a battle between optimism and caution.
What to know
- RealReal’s stock trades nearly 28% below fair value despite AI-powered margin gains and a 35% monthly rally, as investors eye commission and supply risks.
- Workiva won a Strong Buy after posting Q1 2026 GAAP profitability and forecasting $1.5 billion in 2029 revenue, but shares remain down on regulatory and deal-size worries.
- Viavi rocketed 11.6% after joining the S&P MidCap 400, while Verisk faces a yawning valuation gap—analysts tout steady recurring revenue but flag slowing growth and portfolio changes.
AI Upgrades, Investor Caution
Despite AI-fueled efficiency gains and rising fair value targets, RealReal and Workiva both face a disconnect between improved fundamentals and persistent market skepticism about their long-term profit trajectories.
By mid-2026, RealReal (REAL) emerged as a notable example of AI-driven valuation upgrades, with its full-year 2026 outlook enhanced by automation initiatives that boosted operational efficiency and expanded adjusted EBITDA margins. Despite these improvements and double-digit growth in Gross Merchandise Value and revenue, the stock traded at a significant discount—around 27.8% undervalued with a fair value estimate rising from $17.25 to $18.19 per share—reflecting early-stage investor optimism as analysts factored in a transition from losses to positive earnings and a premium multiple on future profits.
Similarly, Workiva (WK) captured growing analyst enthusiasm, receiving a Zacks Investment Research upgrade to a Rank #1 (Strong Buy) in June 2026 after steadily rising earnings estimates over three months. This upgrade was directly linked to Workiva’s Q1 2026 earnings report, which showcased GAAP profitability alongside improved revenue and EPS guidance, driven by operational discipline and surging demand for sustainability reporting. Long-term projections further bolstered optimism, with forecasts of $1.5 billion in revenue and $153.9 million in earnings by 2029, implying a 16.3% annual growth rate and a 60% upside to its current price based on a $78.73 fair value estimate.
Stock Swings Defy Fundamentals
RealReal’s rapid AI-driven rallies and Workiva’s SaaS strength are overshadowed by investor wariness over commission risks, regulatory shifts, and unpredictable deal pipelines.
RealReal's stock performance encapsulates the market's ambivalence toward AI-driven growth narratives, with a striking 35.33% gain over 30 days and 40.68% over 90 days contrasting a 21.20% year-to-date decline. Analysts highlight a 27.8% undervaluation based on a $17.25 fair value per share, fueled by AI-enabled margin expansion and a transition from losses to profitability, yet sales-based metrics and concerns over slipping commission rates and supply plateauing inject caution into investor sentiment.
Workiva presents a counterpoint where robust SaaS fundamentals and AI-driven margin improvement expectations have failed to buoy its stock, which has declined 4.93% over 30 days and 26.61% over one year. Despite rapid ARR growth, high gross margins, and optimistic projections of $1.5 billion revenue by 2029, investor skepticism persists due to regulatory uncertainties, potential shifts in European sustainability rules, and the risk that pauses in large, complex transformation projects could dampen deal sizes and growth prospects.
Viavi’s Index Surge
Viavi’s S&P MidCap 400 inclusion unleashed a wave of institutional buying, driving a 191% year-to-date gain and cementing its status as a breakout midcap performer.
Viavi Solutions experienced a pronounced surge in institutional demand following its inclusion in the S&P MidCap 400 index on June 22, 2026, which propelled its stock price up by 11.6%. This index addition not only sparked immediate buying interest from institutional investors but also amplified positive market sentiment and valuation dynamics, contributing to Viavi's remarkable year-to-date gain of 191%, nearing its 52-week high and reflecting a threefold increase in investment value over five years.
Verisk’s Value Paradox
Verisk’s stable cash flows and high client retention clash with a stubbornly wide valuation gap, as analysts debate whether slow growth and portfolio changes justify the market’s premium.
Analysts maintain a cautious yet balanced valuation narrative for Verisk Analytics as it approaches late 2026, grappling with a significant gap between the company’s fair value estimate around $69.70 and its market price near $187. This divergence stems from concerns over slower revenue growth despite Verisk’s robust margins and highly predictable free cash flow, underpinned by its subscription-heavy model with approximately 83% recurring revenue and 92% client retention. The valuation debate centers on reconciling these durable financial metrics against the tempered growth outlook shaped by recent portfolio simplifications and divestments.
Investor sentiment and analyst outlooks have grown more optimistic ahead of Verisk’s Q2 2026 earnings report, reflecting confidence in the company’s steady growth trajectory despite broader market uncertainties. Management’s emphasis on durable recurring revenue streams, margin expansion, and shareholder-friendly capital returns—including a $1.5 billion accelerated share repurchase and increased dividends—has reinforced a positive valuation narrative. This forward-looking perspective balances AI-driven growth potential with cautious expectations, as analysts anticipate results in line with 2026 guidance, signaling stability amid evolving index compositions and regulatory considerations.
